Pharma Journalist -

Antengene Corporation Limited announced the dosing of the first patient in China in a Phase I/II trial (the HATCH trial) of eltanexor (ATG-016), a next-generation selective inhibitor of…
Read More...

AstraZeneca’s Tagrisso (osimertinib) has been approved in the European Union (EU) for the adjuvant treatment of adult patients with early-stage (IB, II and IIIA) epidermal growth factor…
Read More...

Novartis and Molecular Partners announced the start of the clinical trial EMPATHY, a Phase 2 and 3 study, to explore the use of its novel DARPin therapeutic candidate ensovibep (MP0420)…
Read More...

Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced the launch of the new highly automated DEPArray PLUS, now available with 9 fluorescent…
Read More...

Seelos Therapeutics, Inc. announced it has received European Orphan Drug Designation for SLS-005 in amyotrophic lateral sclerosis (ALS) from the European Medicines Agency (EMA)…
Read More...

Prestige Consumer Healthcare Inc. announced that it has entered into a definitive agreement to acquire a portfolio of over-the-counter consumer brands from specialty pharmaceutical…
Read More...

Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB, a biotech company focused on the…
Read More...

NiKang Therapeutics Inc. a clinical stage biotech company focused on developing innovative small molecule oncology medicines to help patients with unmet medical needs, announced the…
Read More...

We live in an era of increasing digital involvement. Audiences are inundated with more messages than ever before, and the competition for engagement is fierce. So how do you reach…
Read More...

Pieris Pharmaceuticals, Inc., a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases,…
Read More...